Novel coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Control group:Basic medication: Vitamin C effervescent tablets , 1g, QD, taken after brewing with warm boiled water, basic treatment + placebo, 3 tablets/time, 3 times a day, specification 0.4g×9 tabl
experimental group:Basic medication: Vitamin C effervescent tablet , 1g, QD, take after brewing with warm water, basic treatment + Tanreqing capsule, 3 tablets/time, 3 times a day, specification 0.4g×
Sponsors
Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine (North Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Those who conform to the diagnosis of novel coronavirus pneumonia according to the Novel Coronavirus Diagnosis and Treatment Protocol for Pneumonia (Trial Edition 9) and are clinically classified as mild or ordinary type; (2) Aged between 18 and 75, with no gender limitation; (3) Voluntarily accept the drug treatment and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with severe primary respiratory diseases or other pathogenic microbial pneumonia that needs to be differentiated from COVID-19; (2) immune deficiency disease, or use of immunosuppressants or glucocorticoids in the last 3 months; (3) pregnant and lactating women; (4) People with allergic constitution (allergic to more than two drugs or food or known allergic to the drug used in this study); (5) mentally ill persons or persons without self-awareness; (6) Patients whose expected survival time from screening is not more than 48 hours; (7) those who have been intubated or mechanically ventilated at the time of screening; (8) In patients with serious primary diseases of heart, brain, liver and kidney, ALT and AST were 1.5 times higher than the upper limit of normal value; (9) Other conditions that the investigator considers inappropriate for clinical trial participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of major symptoms of COVID-19; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ct values of N gene and ORF gene were detected by novel Coronavirus nucleic acid ;Turn to weight ratio ; | — |
Countries
China
Contacts
Public ContactZhao Ren
Outcome results
None listed